COVID-19

Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19

A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations

A Study of AZD1222, a Vaccine for the Prevention of COVID-19 in Immunocompromised Adults

Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and Death

COVID-19 Antithrombotic Rivaroxaban Evaluation

Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care

Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL)

HENOX: Enoxaparine in Hemodialysis

Enoxaparin in Acute Venous Thromboembolic Disease

Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II)

Study of VYD2311 for the Prevention of COVID-19

Safety and Immunogenicity of NVX-CoV2705

Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of Age

A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2

A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19

A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19

Study of Obeldesivir in Nonhospitalized Participants With COVID-19

Study of Obeldesivir in Participants With COVID-19 Who Have a High Risk of Developing Serious or Severe Illness

Efficacy and Safety of JT001 (VV116) Compared With Paxlovid

To Evaluate the Safety and Efficacy of Inhaled CT-P63 and CT-P66 Combination Therapy in Symptomatic Patients With COVID-19 Not Requiring Supplemental Oxygen

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

Non-inferiority Trial on Treatments in Early COVID-19

Non-inferiority Trial on Monoclonal Antibodies in COVID-19

A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects

Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2

A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above

MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients

ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19

Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients With COVID-19

Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)

AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults

BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.

Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients

Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting

AZD1222 Vaccine for the Prevention of COVID-19

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

Losmapimod Safety and Efficacy in COVID-19

Adaptive COVID-19 Treatment Trial 3 (ACTT-3)

A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19

Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression

Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment

CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1)

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery